Table 2.
Redesign and De Novo Designed Heme Proteins
protein | E°/mV vs NHE | UV–vis absorption (Soret band for heme) | other notes | ref |
---|---|---|---|---|
ME1 | −128 ± 2 | oxidized form: 413 nm | Kd, app = (4.7 ± 1.2) × 10−7 M, 2:1 peptide/hemin stoichiometry | 227 |
reduced form: 427 nm | ||||
CuBMb | copper-free: 77, Cu(II)-bound: 80 | deoxy-CuBMb: 434 nm | oxygen reduction activity | 229,260 |
oxy-CuBMb: 418 nm (not 100% conversion) | ||||
FeBMb | −46 ± 2 | deoxy-FeBMb: 433 nm | nitric oxide reductase activity | 232 |
deoxy-Fe2+-FeBMb: 434 nm | ||||
Fe-porphycene-Mb | −190 ± 15 | oxidized form: 387 nm | enhanced O2 binding affinity | 253 |
reduced form: 375 nm | ||||
oxy-reduced form: 387 nm | ||||
6-propionate Mb | 91.7 ± 1.0 | Met-rMb: 408 nm | (1) Raman shift of deoxy-form: 220 cm−1; (2) pKa(heme-bound water) = 8.67 ± 0.03 | 248 |
ferrous-rMb: 432 nm | ||||
oxy-rMb: 417 nm | ||||
7-propionate Mb | 84.6 ± 1.0 | Met-rMb: 407 nm | (1) Raman shift of deoxy form: 221 cm−1; (2) pKa(heme-bound water) = 8.73 ± 0.03 | 248 |
ferrous-rMb: 431 nm | ||||
oxy-rMb: 417 | ||||
heme-6-propionate Cyt P450cam | oxidized form: 391 nm (in the presence of d-camphor) | (1) Raman shift of the ferric form: 351 cm−1; (2) NADH oxidation rate 1150 μM/μM min enzyme−1 | 251 | |
heme-7-propionate Cyt P450cam | oxidized form: 417 nm (in the presence of d-camphor) | (1) Raman shift of the ferric form: 1503, 1489 cm−1; (2) NADH oxidation rate 27 ± 2 μM/μM min enzyme−1 | 250 | |
PRIME | −97 ± 3, −168 ± 3 | oxidized form: 410 nm | in palmitoyl oleoyl phosphatidylcholine bilayers | 261 |
[Δ7-H10I14I21]2 | −222 | oxidized form: 412 nm (131 000 M−1 cm−1) | Kd1Fe(II) = 42 nM, Kd2Fe(II) = 15 μM | 262 |
reduced form: 427 nm (209 000 M−1 cm−1) | ||||
[Δ7-Pal10I14I21]2 | 58 ± 8 | oxidized form: 410 nm (110 000 M−1 cm−1) | 263 | |
reduced form: 420 nm (144 000 M−1 cm−1) | ||||
[Δ7-H1m10I14I21]2 | reduced form: 431 nm (97 000 M−1 cm−1) | vacant coordination site for CO binding | 264 | |
Fe(PPIX)-[Δ7-H-H3m]2 | −190 ± 10 | oxidized form: 412 nm (123 000 M−1 cm−1) | E° determined at pH 8.0 | 265 |
reduced form: 427 nm (191 00 M−1 cm−1) | ||||
Fe(DADPIX)-[Δ7-H-H3m]2 | −30 ± 10 | oxidized form: 426 nm (89 000 M−1 cm−1) | E° determined at pH 8.0 | 265 |
reduced form: 450 nm (110 000 M−1 cm−1) | ||||
HP7-H7F | −260 ± 6 | oxidized form: 414 nm (129 000 M−1 cm−1) | pKa (His) = 7.3 ± 0.2 | 266 |
reduced form: 428 nm (140 000 M−1 cm−1) | ||||
heme-Ru-MOP2 | −170 ± 6 | oxidized form: 413 nm | electron transfer demonstrated | 267 |
reduced form: 428 nm | ||||
Fe-mimochrome IV | −80 (pH 7.0) | oxidized form: 398 nm | 268 | |
miniperoxidase 3 | oxidized form: 391 nm | HRP activity | 218 | |
immobilized heme-S824C | −153 | oxidized form: 413 nm | binds to N-donor ligands | 269 |